Is myeloperoxidase the key to preventing heart attack and stroke?
Dr James Nadel has published a literature review in Cardiovascular Research which explores the role of myeloperoxidase (MPO) in cardiovascular disease.
Leading Australian heart expert to improve Indigenous health
HRI's Prof Ben Freedman is taking part in a health screening program for atrial fibrillation and high blood pressure to improve Indigenous health.
World-first study to determine if exercise is bad or good for those with congenital heart disease
HRI's world-first exercise study led by Assoc Prof Rachael Cordina could revolutionise the way those with half a heart live their lives.
Why people with sleep apnoea develop high blood pressure and diabetes
Dr Melissa Farnham has been awarded a grant to investigate why people with obstructive sleep apnoea develop high blood pressure and diabetes.
HRI welcomes new Chair, The Hon Peter McGauran
HRI has appointed a new Chair, The Hon Peter McGauran, who is former Federal Science and Technology Minister, and has extensive experience working within the medical sector.
HRI sponsoring 2022 Cardiovascular Postgraduate Scholarship
HRI is sponsoring a new Cardiovascular Postgraduate Scholarship under the Sydney Research Awards and Scholarships program.
One step closer to understanding atherosclerosis
Dr Ashish Misra published a review that brings us one step closer to understanding the inner workings of atherosclerosis, the major cause of stroke and heart attack.
The link between atrial fibrillation (AF or AFib) and dementia
A major new report, led by HRI's Prof Ben Freedman, has confirmed a strong link between atrial fibrillation (irregular heartbeat) and dementia.
Prof Roland Stocker awarded 2021 Basic Science Award
Professor Roland Stocker, leader of the Arterial Inflammation and Redox Biology Group at HRI, has been awarded the 2021 Basic Science Award from the esteemed Society for Free Radical Research-Europe.